Over 40 Questions From Health Canada On How To Prevent Drug Shortages

Expanding the scope of the mandatory public shortage reporting framework and requiring risk management plans for shortages in certain situations are among the actions that Health Canada wants drug companies and other stakeholders to consider in its consultation on improving access to drugs.

Encouraging expanded domestic manufacturing capacity in Canada for select drugs so that there are more than one producer for key medicines is among the actions that are up for discussion in a consultation document from Health Canada on how prevent drug shortages.

Requiring risk management plans for shortages in certain situations and exploring the use of digital strategies to gather information across...